Return to content in this issue

 

The rediscovery of hydroxychloroquine in allergic diseases in the COVID-19 era

Bonzano L1, Cassone G2,3, Tarallo L4, Pellacani G5

1Allergology Service, AUSL Policlinico of Modena, Modena, Italy
2Rheumatology Unit, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria Policlinico di Modena, Modena, Italy
3Rheumatology Unit, IRCCS Arcispedale Santa Maria Nuova, Azienda Unità Sanitaria Locale, Reggio Emilia, Italy
4Department of Orthopaedics Surgery, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria Policlinico di Modena, Modena, Italy
5Dermatology Unit, University of Modena and Reggio Emilia, Modena, Italy

J Investig Allergol Clin Immunol 2021; Vol. 31(1)
doi: 10.18176/jiaci.0575

Key words: COVID-19, hydroxychloroquine, Allergic diseases